Health Canada

Health Canada

January 11, 2011 09:45 ET

Health Canada: Note To Editors

OTTAWA, ONTARIO--(Marketwire - Jan. 11, 2011) - Health Canada today released the January 2011 issue of the Canadian Adverse Reaction Newsletter (CARN).

This issue includes an article on clozapine and a suspected association with rare but potentially life-threatening gastrointestinal problems. Clozapine is an antipsychotic drug used in the treatment of schizophrenia.

As well, it presents a case report of a facial infection suspected of being associated with Bio-Alcamid material that had been implanted in a patient's face several years earlier. Bio-Alcamid is an injectable soft tissue prosthesis used to restore facial volume in HIV patients following antiretroviral therapy.

Finally, the newsletter contains an editorial on important information to include when reporting adverse reactions involving natural health products to Health Canada, along with a quarterly summary of health professional and consumer advisories.

The January 2011 edition of CARN can be viewed on the Health Canada Web site at:

Contact Information

  • Media Inquiries:
    Health Canada
    Media Relations